Company Overview

Business Description

Sector
Health Care
Industry
Life Sciences Tools & Services
Headquarters
United Kingdom UK
Employees
1 335
IPO date
Sep 30, 2021

Oxford Nanopore Technologies makes DNA and RNA sequencing systems that let customers read genetic material by passing it through tiny nanopores. Its products include handheld and lab-based sequencers, sample prep kits, flow cells, and analysis software. The company sells these tools to research labs, hospitals, universities, biotech firms, and government agencies that need fast genetic data.

The business makes money mainly by selling instruments and, more importantly, by recurring sales of consumables such as flow cells and reagents used in each sequencing run. It also earns from software and service offerings tied to data analysis and workflow support. This matters because once a customer installs the platform, it tends to keep buying the disposable parts needed to keep sequencing.

What makes Oxford Nanopore different is its sequencing method. Instead of relying on large centralized machines, it uses portable devices and a technique that can read long stretches of DNA or RNA in real time. That gives it a strong role in areas like field research, infectious disease monitoring, genomics, and clinical testing, where speed, portability, and long-read data are especially valuable.

Oxford Nanopore Technologies PLC Investor Relations

Address
Oxford Science Park, Gosling Building, Edmund Halley Road
Oxford
United Kingdom

Business Segments

Sequencing systems

Oxford Nanopore designs and sells DNA and RNA sequencing devices, from small portable units to larger lab systems, that read genetic material for research and testing workflows.

Customers and revenue model

Consumables and analysis

The company sells flow cells, sample preparation kits, reagents, and analysis software that customers use with its sequencing devices to run tests and interpret results.

Customers and revenue model

Management

Dr. James Spike Willcocks

Chief Strategy Officer

Biography unavailable

Prof. Hagan Bayley Ph.D.

Co-Founder & Member of Technical Advisory Board

Biography unavailable

Mr. Nicholas Patrick Keher

CFO & Director

Biography unavailable

Mr. Lakmal Jayasinghe

Chief Scientific Officer

Biography unavailable

Mr. John Schoellerman

Senior Vice President of Corporate & Business Development

Biography unavailable

Ms. Rosemary Sinclair Dokos M.B.A.

Chief Product & Marketing Officer

Biography unavailable

Mr. Richard Compton

Senior Vice President of Sales & Commercial Operations

Biography unavailable

Ms. Sarah Lapworth

Senior Vice President of Global Human Resources

Biography unavailable

Ms. Zoe McDougall

Global Head & Senior VP of Corporate Affairs

Biography unavailable

Kathleen Barnes

Senior Vice President of Population Health & Precision Medicine

Biography unavailable

1 / 10